Rory B. Riggs - Mar 29, 2022 Form 4 Insider Report for Royalty Pharma plc (RPRX)

Role
Director
Signature
/s/ Jason Mehar, as Attorney-in-Fact for Rory B. Riggs
Stock symbol
RPRX
Transactions as of
Mar 29, 2022
Transactions value $
-$2,315,322
Form type
4
Date filed
3/30/2022, 06:46 PM
Previous filing
Mar 21, 2022
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RPRX Class A Ordinary Shares Sale -$2.32M -60K -9.07% $38.59 602K Mar 29, 2022 Direct F1
holding RPRX Class A Ordinary Shares 85.2K Mar 29, 2022 By New Ventures III LLC
holding RPRX Class A Ordinary Shares 15K Mar 29, 2022 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.51 to $38.74 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.